NCT03509623View on ClinicalTrials.gov

Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 2, 2017

Primary Completion Date

March 26, 2018

Study Completion Date

April 27, 2018

Conditions
Neovascular Age-related Macular Degeneration
Interventions
DIAGNOSTIC_TEST

Blood sampling through direct peripheral venous puncture

Fasting blood samples will be collected 10-15 minutes before the first intravitreal injection of aflibercept and at 7 and 30 days post-injection using a 19-gauge needle under minimum stasis. Blood coagulation parameters will be evaluated.

Trial Locations (1)

26504

University Hospital of Patras, Pátrai

All Listed Sponsors
lead

University Hospital of Patras

OTHER

NCT03509623 - Blood Coagulation Parameters in Patients Receiving Intravitreal Aflibercept for Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter